tinea%20capitis
TINEA CAPITIS
Tinea capitis  is a contagious dermatophytosis affecting the hair shaft and follicles of the scalp, eyebrows and eyelashes.
It is most common in the crowded areas as infection originates from contact with a pet or an infected person and asymptomatic carriage persists indefinitely.
It primarily affects children 3-7 years of age.
The causative agents are the genus Trichophyton and Microsporum.
Cardinal clinical feature is the combination of inflammation with hair breakage and loss.
  1. Berg D, Erickson P. Fungal infections in children: new developments and treatments. Postgrad Med. 2001 Jul;110(1):83-84,87-88,93-94. PMID: 11467045
  2. Elewski BE. Tinea capitis: a current perspective. J Am Acad Dermatol. 2000 Jan;41(1)(Pt 1):1-20. PMID: 10607315
  3. Andrews MD, Burns M. Common tinea infections in children. Am Fam Physician. 2008 May;77(10):1415-1420. PMID: 18533375
  4. Fuller LC, Child FJ, Midgley G, et al. Diagnosis and management of scalp ringworm. Br Med J. 2003 Mar;326(7388):539-541. PMID: 12623917
  5. Elewski BE. Treatment of tinea capitis: beyond griseofulvin. J Am Acad Dermatol. 1999 Jun;40(6)(Pt 2):S27-S30. PMID: 10367913
  6. Hainer BL. Dermatophyte infections. Am Fam Physician. 2003 Jan;67(1):101-108. PMID: 12537173
  7. Higgins EM, Fuller LC, Smith CH. Guidelines for the management of tinea capitis. Br J Dermatol. 2000 Jul;143(1):53-58. PMID: 10886135
  8. Raimer SS. New and emerging therapies in pediatric dermatology. Dermatol Clin. 2000 Jan;18(1):73-78. PMID: 10626113
  9. Moossavi M, Bagheri B, Scher RK. Systemic antifungal therapy. Dermatol Clin. 2001 Jan;19(1):35-52. PMID: 11155585
  10. Sladden M, Johnston G. Common skin infections in children. Br Med J. 2004 Jul;329(7457):329, 95-99. PMID: 15242915
  11. Strober BE. Tinea capitis. Dermatol Online J. 2001 Feb;7(1):12. PMID: 11328633
  12. Vander-Straten MR, Hossain MA, Ghannoum MA. Cutaneous infections: dermatophytosis, onychomycosis and tinea versicolor. Infect Dis Clin N Am. 2003 Mar;17(1):87-112. PMID: 12751262
  13. Aaron DM. Tinea capitis. Merck Manual; 2013 Mar. http://www.merckmanuals.com/professional/dermatologic_disorders/fungal_skin_infections/tinea_capitis.html. Accessed 23 Aug 2013
  14. Gilbert DN, Moellering RC, Eliopoulos GM, et al. The Sanford guide to antimicrobial therapy. 37th ed. Sperryville, VA: Antimicrobial Therapy Inc; 2007
  15. Habif TP. Superficial fungal infections. Clinical dermatology: a color guide to diagnosis and therapy. 4th ed. Pennsylvania: Mosby, Elsevier; 2004:409-439
  16. MedWormhttp://www.medworm.com/rss/index.php/Dermatology/12/http://www.medworm.com/rss/medicalfeeds/specialities/Dermatology.xml
  17. MedWormhttp://www.medworm.com/rss/index.php/Pediatrics/33/http://www.medworm.com/rss/medicalfeeds/specialities/Pediatrics.xml
  18. Goldstein AO, Goldstein BG. Dermatophyte (tinea) infections. UpToDate. http://www.uptodate.com/contents/dermatophyte-tinea-infections. Jul 2013. Accessed 23 Aug 2013
  19. Kao GF. Tinea capitis. eMedicine. http://www.emedicine. com/DERM/topic420.htm
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 6 days ago

Beta-blockers could reduce mortality risk in patients with heart failure with reduced ejection fraction (HFrEF) and moderate or moderately-severe renal dysfunction without causing harm, according to the BB-META-HF* trial presented at ESC 2019.

6 days ago
Blood pressure (BP) in children is influenced by early-life exposure to several chemicals, built environment and meteorological factors, suggests a study.
6 days ago
Short sleep duration is associated with an increased risk of myocardial infarction (MI), according to prospective observational and Mendelian randomization (MR) analyses.
Tristan Manalac, 6 days ago
The addition of ezetimibe improves statin treatment in acute coronary syndrome (ACS) patients with dyslipidaemia and low eicosapentaenoic acid-to-arachidonic acid (EPA/AA) ratio, resulting in a lowered risk of cardiovascular events compared to monotherapy, according to a study presented at the recently concluded 2019 Congress of the European Society of Cardiology (ESC 2019) held in Paris, France.